BioCardia Receives FDA Clearance for AVANCE Steerable Introducer for Transseptal Access to Heart
May 08, 2019 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
IlluminOss Medical Receives Clearance to Expand Clinical Indications in the U.S.
September 13, 2018 09:00 ET
|
IlluminOss Medical
EAST PROVIDENCE, R.I. , Sept. 13, 2018 (GLOBE NEWSWIRE) -- IlluminOss Medical, a privately held, commercial-stage medical device company focused on minimally invasive orthopedic fracture repair,...
BioCorRx Provides Business Update for the Second Quarter of 2018
August 15, 2018 08:00 ET
|
BioCorRx Inc
ANAHEIM, CA, Aug. 15, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, today provided...
Integer Receives FDA Approval for Thin Wall Radial Introducer Kit, RadialSeal™
July 31, 2018 13:45 ET
|
Integer Holdings Corporation
PLYMOUTH, Minn., July 31, 2018 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (“Integer”) (NYSE:ITGR), a leading medical device outsource manufacturer, announced today that it has received FDA and...
AngioSoma, Inc. Announces Selection of Regulatory Firm for Flagship Drug
June 18, 2018 11:44 ET
|
AngioSoma, Inc.
HOUSTON, TX, June 18, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (SOAN) is excited to announce that we have identified a regulatory firm who can assist taking our patented flagship drug, Liprostin™,...
Wright Medical Group N.V. Announces FDA Premarket Approval for AUGMENT® Injectable Bone Graft
June 13, 2018 06:00 ET
|
Wright Medical Group N.V.
Clinically Proven, Cost-Effective, Injectable Formulation of AUGMENT® Approved in U.S. for Ankle and/or Hindfoot Fusion Company Can Now Initiate Commercial Sale and Distribution in the U.S. Company...
BioElectronics Receives FDA Pre-Submission Approval for its Post-Operation Pain Market Clearance Application
May 29, 2018 11:48 ET
|
BioElectronics Corporation
FREDERICK, MD, May 29, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com reports that it has cancelled today’s scheduled US Food and Drug Administration meeting....
VESTEX® Active Barrier Healthcare Scrubs First-Ever to Receive FDA Designation as Class II Medical Device
May 23, 2018 08:00 ET
|
Vestagen Protective Technologies, Inc.,
Orlando, Fla., May 23, 2018 (GLOBE NEWSWIRE) -- Vestagen Protective Technologies, Inc., which develops and markets healthcare worker uniforms, scrubs, lab coats and other garments utilizing its...
IlluminOss Medical Granted FDA Marketing Clearance for the IlluminOss® Bone Stabilization System
January 09, 2018 09:00 ET
|
IlluminOss Medical
EAST PROVIDENCE, R.I., Jan. 09, 2018 (GLOBE NEWSWIRE) -- IlluminOss Medical, a privately held, commercial-stage medical device company focused on minimally invasive orthopedic fracture repair, today...
BioCorRx Selects Covance for Non-Clinical Studies, Announces the Addition of Dr. Bal S. Brar to its Drug Development Team, Plans Pre-IND Meeting with FDA
November 28, 2016 06:00 ET
|
BioCorRx
ANAHEIM, CA, Nov. 28, 2016 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTC PINK: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions,...